Somatostatin analogues therapy in gastroenteropancreatic neuroendocrine tumours: current aspects and new perspectives

Gastroenteropancreatic neuroendocrine tumours (GEP NETs) are rare tumours that present many clinical features secreting peptides and neuroamines that cause distinct clinical syndromes such as carcinoid syndrome. However most of them are clinically silent until late presentation with mass effects. Su...

Ausführliche Beschreibung

Bibliografische Detailangaben

1. Verfasser:	Roberto eBaldelli
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2014-02-01
Schriftenreihe:	Frontiers in Endocrinology
Schlagworte:	Neuroendocrine Tumors Octreotide carcinoid somatostatin analogs lanreotide
Online-Zugang:	http://journal.frontiersin.org/Journal/10.3389/fendo.2014.00007/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!